PRACTICE ALERT PODCAST

Aspirin as CVD prevention in seniors? Think twice

J Fam Pract. 2018 December;67(12):audio
By
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

Against a backdrop of the US Preventive Services Task Force recommendations on the use of aspirin to prevent cardiovascular disease (CVD), Dr. Campos-Outcalt summarizes the findings of an October 2018 aspirin study published in The New England Journal of Medicine. The study gives physicians reason to pause before using aspirin as primary prevention for CVD in older adults.

 

Resources

US Preventive Services Task Force. Final recommendation statement: Aspirin use to prevent cardiovascular disease and colorectal cancer: preventive medication.
https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/aspirin-to-prevent-cardiovascular-disease-and-cancer.
Published April 2016. Accessed September 14, 2018.

McNeil JJ, Woods RL, Nelson MR, et al. Effect of aspirin on disability-free survival in the healthy elderly. 2018;379:1499-1508.
https://www.nejm.org/doi/full/10.1056/NEJMoa1800722. Accessed November 7, 2018.

McNeil JJ, Nelson MR, Woods JE, et al. Effect of aspirin on all-cause mortality in the healthy elderly. 2018;379:1519-1528.
https://www.nejm.org/doi/full/10.1056/NEJMoa1803955. Accessed November 7, 2018.

Next Article:

ARISTOPHANES: Apixaban edges other DOACS for octogenarians